- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00192816
Pain Perception in Alzheimer's Disease
September 13, 2005 updated by: Rambam Health Care Campus
The purpose of this study is to determine response to pain in Alzheimer's disease.We plan to study the effect of diffuse noxious inhibitory controls(counterirritation phenomenon)and the autonomic nervous system reaction(reflected by the heart rate) in Alzheimer's disease.
The study's hypothesis is that pain perception and autonomic nervous system reaction are altered in Alzheimer's disease.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maria Nassar, Doctor
- Phone Number: 0502061707
- Email: mashers@netvision.net.il
Study Locations
-
-
-
Haifa, Israel, 31096
- Recruiting
- Neurocognitive unit,Neurophysiology laborator Rambam Health Care Campus
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 95 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of Alzheimer's disease Must be able to understand a simple pain scale
Exclusion Criteria:
Neuropathy Psychotropic drugs use -
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Judith Aharon-Peretz, Rambam Health Care Campus
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2005
Study Registration Dates
First Submitted
September 13, 2005
First Submitted That Met QC Criteria
September 13, 2005
First Posted (Estimate)
September 19, 2005
Study Record Updates
Last Update Posted (Estimate)
September 19, 2005
Last Update Submitted That Met QC Criteria
September 13, 2005
Last Verified
September 1, 2005
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2038CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia Alzheimer Type
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompleted
-
Istanbul University - Cerrahpasa (IUC)Not yet recruitingDementia, Alzheimer Type | Alzheimer's Disease | Alzheimer DementiaTurkey
-
Cognito Therapeutics, Inc.RecruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
Whanin Pharmaceutical CompanyCompletedAlzheimer Type DementiaKorea, Republic of
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Dementia, Alzheimer Type | Dementia Alzheimers | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Dementia, MildUnited States
-
Chase Pharmaceuticals Corporation, an affiliate...CompletedDementia of Alzheimer's TypeUnited States
-
Charite University, Berlin, GermanyWithdrawnDementia of Type AlzheimerGermany
-
Emory UniversityAbbottCompletedDementia | Alzheimer Disease | Dementia, Alzheimer Type | Senile Dementia, Alzheimer TypeUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingDementia of Alzheimer Type | Dementia, MildItaly
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
Clinical Trials on reaction to pain
-
Assistance Publique - Hôpitaux de ParisAgence de La BiomédecineUnknownPregnancy Outcome | ICSI | Assisted Reproductive Technique | Acrosome ReactionFrance
-
Maimónides Biomedical Research Institute of CórdobaCompletedEffectiveness of the Multicomponent Therapy in Chronic Pain Through The Use of Smartphones (NO+PAIN)Chronic Pain | Pain, Chronic | Cognitive Therapy | Catastrophization | Acceptance, Social | SmartphonesSpain
-
University Hospital, LilleCompleted
-
University Hospital, LilleNot yet recruiting
-
University of SaskatchewanSaskatchewan Health Research Foundation; Ralston Brothers Grant (Kelsey Trail...Completed
-
VA Office of Research and DevelopmentCompleted
-
Michigan State UniversityChildren's Hospital Medical Center, Cincinnati; American Pain SocietyCompletedAnxiety | Functional Abdominal Pain SyndromeUnited States
-
Montefiore Medical CenterAlbert Einstein College of MedicineRecruitingMental Health | Adolescent Idiopathic Scoliosis (AIS)United States
-
Elosan AGCompletedChronic PainSwitzerland
-
John H. Stroger HospitalUniversity of Illinois at ChicagoUnknownPituitary TumorUnited States